Results 1 to 10 of about 28,927 (234)

Acquired Angioedema Due to C1 inhibitor Deficiency Caused by Non-Hodgkin Lymphoma in a Patient with Myasthenia Gravis

Romanian Journal of Laboratory Medicine, 2021
Acquired angioedema due to C1-inhibitor deficiency is a very rare disorder that usually appears in patients with lymphoproliferative and/or autoimmune diseases.
Bara Noémi, Nadasan Valentin, Varga Lilian, Farkas Henriette   +3 more
doaj   +1 more source

A clinical pathway for the diagnosis of sesame allergy in children

World Allergy Organization Journal, 2022
Background: Sesame allergy (SA) is a common cause of life-threatening, persistent food allergy, not only in the Middle East and Asia, but increasingly worldwide. Commercially available tests such as extracts for skin testing or specific IgE for sesame or
Diti Machnes-Maayan, MD, Soad Haj Yahia, MD, Shirly Frizinsky, MD, Ramit Maoz-Segal, MD, Irena Offengenden, MD, Ron S. Kenett, PhD, Mona I. Kidon, MD, Nancy Agmon-Levin, MD   +7 more
doaj   +1 more source

The analysis of the effect of the COVID-19 pandemic on patients with hereditary angioedema type I and type II

Scientific Reports, 2023
Due to the similarity between the pathomechanism of SARS-CoV-2 infections and hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE), a possibility emerged that C1-INH-HAE may worsen the course of the infection, or that the infection may ...
Dávid Szilágyi, Hanga Réka Horváth, Noémi Andrási, Miklós Soma Kempler, Zsuzsanna Balla, Henriette Farkas   +5 more
doaj   +1 more source

Late Hypersensitivity Reactions to the BNT162b2 SARS-CoV-2 Vaccine Are Linked to Delayed Skin Sensitization and Prior Exposure to Hyaluronic Acid

Life, 2022
Background: Late hypersensitivity reactions (HSRs) to the BNT162b2-vaccine have raised concerns regarding its safety, particularly as further immunizations are required. The yield of skin testing with the BNT162b2v is unclear, as well as the risk factors
Ramit Maoz-Segal, Ronen Shavit, Mona Iancovici Kidon, Irena Offengenden, Diti Machnes-Maayan, Yulia Lifshitz-Tunitsky, Stanley Niznik, Nancy Agmon-Levin   +7 more
doaj   +1 more source

Long term follow-up of complement parameters to improve the management of acquired angioedema due to C1-inhibitor deficiency

Heliyon, 2022
Acquired angioedema due to C1-inhibitor deficiency (C1–INH-AAE) is a rare disease that can be diagnosed via complement testing. It often accompanies lymphoproliferative underlying diseases.
Zsofia Polai, Zsuzsanna Balla, Lilian Varga, Szabolcs Benedek, Henriette Farkas   +4 more
doaj   +1 more source

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series

Allergy, Asthma & Clinical Immunology, 2022
Background Hereditary angioedema (HAE) is characterized by potentially severe and life-threatening attacks of localized swelling. Prophylactic therapies are available, including attenuated androgens. Efficacy of attenuated androgens has not been assessed
Marcus Maurer, Markus Magerl, Emel Aygören-Pürsün, Konrad Bork, Henriette Farkas, Hilary Longhurst, Sorena Kiani‑Alikhan, Laurence Bouillet, Isabelle Boccon-Gibod, Mauro Cancian, Andrea Zanichelli, David Launay   +11 more
doaj   +1 more source

The characteristics of upper airway edema in hereditary and acquired angioedema with C1‐inhibitor deficiency

Clinical and Translational Allergy, 2021
Background Angioedemas localized in the upper airway are potentially life threatening, and without proper treatment, they may lead to death by suffocation. Upper airway edemas (UAE) in bradykinin‐mediated angioedemas can even be the first symptoms of the
Zsuzsanna Balla, Noémi Andrási, Zsófia Pólai, Beáta Visy, Ibolya Czaller, György Temesszentandrási, Dorottya Csuka, Lilian Varga, Henriette Farkas   +8 more
doaj   +1 more source

C1-inhibitor/C1-inhibitor antibody complexes in acquired angioedema due to C1-inhibitor deficiency

Orphanet Journal of Rare Diseases, 2023
Background Autoantibodies against C1-inhibitor (C1-INH-Ab) have a diagnostic value in acquired angioedema due to C1-inhibitor deficiency (C1-INH-AAE), even though antibodies can circulate in complexes, which can be undetectable by proven methods. Our aim
Zsofia Polai, Erika Kajdacsi, Laszlo Cervenak, Zsuzsanna Balla, Szabolcs Benedek, Lilian Varga, Henriette Farkas   +6 more
doaj   +1 more source

Hypersensitivity reactions amongst Hungarian Patients with Hereditary Angioedema due to C1-Inhibitor Deficiency

World Allergy Organization Journal, 2023
Background: In hereditary angioedema (HAE) due to C1-inhibitor deficiency (C1-INH-HAE), bradykinin-mediated submucosal and/or subcutaneous angioedema dominates the clinical picture.
Hanga Réka Horváth, MD, Dávid Szilágyi, MD, Noémi Andrási, MD, Zsuzsanna Balla, MD, PhD, Beáta Visy, MD, PhD, Henriette Farkas, MD, PhD, DSc   +5 more
doaj   +1 more source

Patient‐physician interactions in hereditary angioedema—Key learnings from the coronavirus disease 2019 pandemic

Clinical and Translational Allergy, 2023
Background The coronavirus disease pandemic and its containing measures have caused concerns for patients with hereditary angioedema (HAE) and their treating physicians.
Marcus Maurer, Thomas Buttgereit, Markus Magerl, Kathrin Schön, Zsusanna Balla, Henriette Farkas   +5 more
doaj   +1 more source